Literature DB >> 6971663

Pure red cell aplasia and hypogammaglobulinemia associated with Tr-cell chronic lymphocytic leukemia.

T Nagasawa, T Abe, T Nakagawa.   

Abstract

A 72-yr-old male with Tr-cell chronic lymphocytic leukemia (Tr-CLL) exhibited pure red cell aplasia (PRCA) and hypogammaglobulinemia. During a remission of Tr-CLL, and while receiving cyclophosphamide therapy, he recovered from PRCA and hypogammaglobulinemia. To investigate the pathogenesis of PRCA and hypogammaglobulinemia, we used coculture techniques to study the effect of the malignant Tr cells on erythroid colony formation and B-cell differentiation to immunoglobulin-producing cells. Varying numbers of malignant Tr cells (2 X 10 to 2 X 10(5) cells) were cocultured with 2 X 10(5) normal bone marrow cells. The malignant Tr cells caused a marked reduction of erythroid colony formation in the plasma clot system. This suppression of erythroid colony formation was reversed when the malignant Tr cells were pretreated with antilymphocyte serum and complement. There was no evidence of inhibitory effects in the serum or the supernatant media of the malignant Tr cells stimulated with phytohemagglutinin (PHA). The malignant Tr cells, stored at --80 degrees C before transfusion, were also capable of suppressing autologous erythroid colony formation after recovery from PRCA. In addition, malignant Tr cells were found to have strong suppressor activity against the immunoglobulin biosynthesis by allogeneic B cells. The in vitro suppressions of both erythroid colony formation and B-cell differentiation provide an explanation for the association of PRCA and hypogammaglobulinemia with Tr-CLL.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6971663

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Lymphocytosis of large granular lymphocytes associated with anemia and neutropenia: proof of monoclonality of the LGL-population, but benign clinical course.

Authors:  S Serke; A Neubauer; D Huhn
Journal:  Klin Wochenschr       Date:  1989-06-01

2.  Pure red cell aplasia and thymoma associated with high levels of the suppressor/cytotoxic T lymphocyte subset.

Authors:  J P Milnes; B P Goorney; T B Wallington
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-17

Review 3.  A lymphoproliferative disorder of the large granular lymphocytes with natural killer activity.

Authors:  M Ferrarini; S Romagnani; E Montesoro; A Zicca; G F Del Prete; A Nocera; E Maggi; A Leprini; C E Grossi
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

4.  T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia.

Authors:  K F Mangan; G Chikkappa; P C Farley
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

5.  Feline glucose-6-phosphate dehydrogenase cellular mosaicism. Application to the study of retrovirus-induced pure red cell aplasia.

Authors:  J L Abkowitz; R L Ott; J M Nakamura; L Steinmann; P J Fialkow; J W Adamson
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

6.  Successful treatment of acquired pure red cell aplasia with oral corticosteroids in a patient with B-cell CLL.

Authors:  Pramila Dharmshaktu; Naresh Gupta; Dinesh Kumar Dhanwal
Journal:  BMJ Case Rep       Date:  2013-11-14

7.  Serum erythropoietic inhibitors in patients with pure red cell aplasia.

Authors:  M Takahashi; K Nikkuni; I Tanaka; T Furukawa; Y Moriyama; A Shibata; S Satoh; Y Kuwabara; Y Maruyama; Y Matsunaga
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

8.  A lymphoproliferative disorder of granular lymphocytes with a novel phenotype and suppressor function.

Authors:  A Landay; M C Poon; L T Clement; C E Grossi
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

9.  T cells in patients with chronic T gamma lymphocytosis: morphology, cytochemistry, ultrastructure and immunological characteristics.

Authors:  J W Smit; N R Blom; M J van Luyn; F Miedema; C J Melief; M R Halie
Journal:  Blut       Date:  1985-08

10.  T gamma lymphocytosis is clinically non-progressive but immunologically heterogeneous.

Authors:  F Miedema; F G Terpstra; J W Smit; J P van der Veen; C J Melief
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.